PROCESSING OF LAP SIGNALS

• US 20140257070A1
• Filed: 06/20/2011
• Published: 09/11/2014
• Est. Priority Date: 06/20/2011
• Status: Abandoned Application

• Current Assignee: St. Jude Medical AB (Abbott Laboratories Incorporated)
• Original Assignee: St. Jude Medical AB (Abbott Laboratories Incorporated)
• Inventors: Blomqvist, Andreas, Noren, Kjell
• Application Number:
  US13/517,009
• Publication Number:
  US 20140257070A1
• Time in Patent Office: Days
• US Class Current: 600/374
• CPC Class Codes: A61B 5/02028 Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
• CPC Class Codes: A61B 5/0215 by means inserted into the body catheters A61M25/00
• CPC Class Codes: A61B 5/287 Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
• CPC Class Codes: A61B 5/346 Analysis of electrocardiograms
• CPC Class Codes: A61B 5/366 Detecting abnormal QRS complex, e.g. widening
• CPC Class Codes: A61B 5/7239 using differentiation including higher order derivatives
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36564 controlled by blood pressure

Abstract

Cardiac valve events are monitored by recording a left atrial pressure (LAP) representing signal using an implantable pressure sensor (50). The LAP signal is processed in order to generate a derivative LAP signal representative of the first time derivative of the LAP signal. The opening of the aortic valve of the heart is then identified to coincide in time with a minimum in the derivative LAP signal following ventricular depolarization in a cardiac cycle.

Claims

1. A system for determining cardiac events, said system comprising:

a connector connectable to an implantable pressure sensor configured to generate a left atrial pressure, LAP, signal representative of a left atrial pressure of a subject during at least one cardiac cycle;

a derivative processor configured to process said LAP signal and generate a derivative LAP signal representative of a first time derivative of said LAP signal; and

an aortic valve opening identifier configured to process said derivative LAP signal and identify a time point of opening of an aortic valve of a heart in said subject to coincide with a time point of a minimum in said derivative LAP signal following depolarization of ventricles of said heart for a cardiac cycle.

2. The system according to claim 1, wherein said aortic valve opening identifier is configured to identify said time point of opening of said aortic valve to coincide with a time point of a global minimum in said derivative LAP signal during said cardiac cycle.

3. The system according to claim 1, further comprising:

an electrogram processor configured to generate an electrogram signal representative of electric activity of said heart during said at least one cardiac cycle; and

a QRS onset identifier configured to process said electrogram signal and identify said depolarization of ventricles to coincide with a time point of onset of a QRS complex for said cardiac cycle.

4. The system according to claim 1, wherein said connector is connectable to at least one ventricular lead having at least one electrode configured to be arranged in or in connection with a ventricle of said heart, said system further comprising a ventricular pulse generator configured to generate pacing pulses applied to said ventricle using said at least one ventricular lead to trigger said depolarization of said ventricles.

5. The system according to claim 1, further comprising:

an electrogram processor configured to generate an electrogram signal representative of electric activity of said heart during said at least one cardiac cycle;

a QRS onset identifier configured to process said electrogram signal and identify a time point of onset of a QRS complex for said cardiac cycle; and

a pre-ejection period processor configured to calculate a pre-ejection period parameter value for said subject based on a difference between said time point of onset of said QRS complex and said time point of opening of said aortic valve.

6. The system according to claim 5, further comprising:

an aortic valve closure identifier configured to process said derivative LAP signal and identify a time point of closure of said aortic valve to coincide with a time point of a maximum in said derivative LAP signal following said minimum in said derivative LAP signal for said cardiac cycle; and

an ejection time processor configured to calculate an ejection time parameter value for said subject based on a difference between said time point of opening of said aortic valve and said time point of closure of said aortic valve.

7. The system according to claim 6, further comprising a systolic time ratio processor configured to calculate a systolic time ratio parameter value for said subject based on a quotient between said pre-ejection period parameter value and said ejection time parameter value.

8. The system according to claim 7, further comprising an ejection fraction processor configured to calculate an ejection fraction parameter value for said subject as 0.84−

0.64×

STR, wherein STR denotes said systolic time ratio parameter value.

9. The system according to claim 1, further comprising:

an aortic valve closure identifier configured to process said derivative LAP signal and identify a time point of closure of said aortic valve to coincide with a time point of a maximum in said derivative LAP signal following said minimum in said derivative LAP signal for said cardiac cycle;

a mitral valve opening identifier configured to process said LAP signal and identify a time point of opening of a mitral valve of said heart in said subject to coincide with a time point of a maximum of a V-wave in said LAP signal for said cardiac cycle; and

an isovolumetric relaxation time processor configured to calculate an isovolumetric relaxation time parameter value for said subject based on a difference between said time point of closure of said aortic valve and said time point of opening of said mitral valve.

10. The system according to claim 1, further comprising:

a mitral valve closure identifier configured to process said LAP signal and identify a time point of closure of a mitral valve of said heart in said subject to coincide with a time point of a maximum of an A-wave in said LAP signal for said cardiac cycle; and

an isovolumetric contraction time processor configured to calculate an isovolumetric contraction time parameter value for said subject based on a difference between said time point of closure of said mitral valve and said time point of opening of said aortic valve.

11. The system according to claim 6, further comprising a myocardial performance index processor configured to calculate a myocardial performance index parameter value (MPI) for said subject based on a quotient between a sum of said isovolumetric relaxation time parameter value (IRT) and said isovolumetric contraction time parameter value (ICT) and said ejection time parameter value (ET),

12. The system according to claim 1, wherein said connector, said derivative processor and said aortic valve opening identifier are implemented in an implantable medical device and wherein said connector is connectable to at least one cardiac lead having at least one electrode configured to sense electrical activity of said heart.

13. The system according to claim 1, wherein said connector is implemented in an implantable medical device having a transceiver configured to transmit information of said LAP signal to a transceiver of a non-implanted data processing device comprising said derivative processor and said aortic valve opening identifier.

14. A method for identifying cardiac valve events, said method comprising:

generating a left atrial pressure, LAP, signal representative of a left atrial pressure of a subject during at least one cardiac cycle;

calculating, based on said LAP signal, a derivative LAP signal representative of a first time derivative of said LAP signal; and

identifying a time point of opening of an aortic valve of a heart in said subject to coincide with a time point of a minimum in said derivative LAP signal following depolarization of ventricles of said heart for a cardiac cycle.

15. The method according to claim 14, wherein identifying said time point of opening of said aortic valve comprises identifying said time point of opening of said aortic valve to coincide with a time point of a global minimum in said derivative LAP signal during said cardiac cycle.

16. The method according to claim 14, further comprising:

generating an electrogram signal representative of electric activity of said heart during said at least one cardiac cycle; and

identifying, by processing said electrogram signal, said depolarization of ventricles to coincide with a time point of onset of a QRS complex for said cardiac cycle.

17. The method according to claim 14, further comprising generating pacing pulses applied to a ventricle of said heart by at least one ventricular lead having at least one electrode configured to be arranged in or in connection with said ventricle to trigger said depolarization of said ventricles.

18. The method according to claim 14, further comprising:

generating an electrogram signal representative of electric activity of said heart during said at least one cardiac cycle;

identifying, by processing said electrogram signal, a time point of onset of a QRS complex for said cardiac cycle; and

calculating a pre-ejection period parameter value for said subject based on a difference between said time point of onset of said QRS complex and said time point of opening of said aortic valve.

19. The method according to claim 18, further comprising:

identifying a time point of closure of said aortic valve to coincide with a time point of a maximum in said derivative LAP signal following said minimum in said derivative LAP signal for said cardiac cycle; and

calculating an ejection time parameter value for said subject based on a difference between said time point of opening of said aortic valve and said time point of closure of said aortic valve.

20. The method according to claim 19, further comprising calculating a systolic time ratio parameter value for said subject based on a quotient between said pre-ejection period parameter value and said ejection time parameter value.

21. The method according to claim 20, further comprising calculating an ejection fraction parameter value for said subject as 0.84−

0.64×

STR, wherein STR denotes said systolic time ratio parameter value.

22. The method according to claim 14, further comprising:

identifying a time point of closure of said aortic valve to coincide with a time point of a maximum in said derivative LAP signal following said minimum in said derivative LAP signal for said cardiac cycle;

identifying a time point of opening of a mitral valve of said heart in said subject to coincide with a time point of a maximum of a V-wave in said LAP signal for said cardiac cycle; and

calculating an isovolumetric relaxation time parameter value for said subject based on a difference between said time point of closure of said aortic valve and said time point of opening of said mitral valve.

23. The method according to claim 14, further comprising:

identifying a time point of closure of a mitral valve of said heart in said subject to coincide with a time point of a maximum of an A-wave in said LAP signal for said cardiac cycle; and

calculating an isovolumetric contraction time parameter value for said subject based on a difference between said time point of closure of said mitral valve and said time point of opening of said aortic valve.

24. The method according to claim 19, further comprising calculating a myocardial performance index parameter value (MPI) for said subject based on a quotient between a sum of said isovolumetric relaxation time parameter value (IRT) and said isovolumetric contraction time parameter value (ICT) and said ejection time parameter value (ET),